Články se zplnomocněním k veřejnému přístupu - Yang YangDalší informace
Dostupné někde: 43
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
Y Yang, L Wang, P Bell, D McMenamin, Z He, J White, H Yu, C Xu, ...
Nature biotechnology 34 (3), 334-338, 2016
Zplnomocnění: US National Institutes of Health
Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor
J Li, Y Yang, L Huang
Journal of controlled release 158 (1), 108-114, 2012
Zplnomocnění: US National Institutes of Health
Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy
Y Wang, H Su, Y Yang, Y Hu, L Zhang, P Blancafort, L Huang
Molecular Therapy 21 (2), 358-367, 2013
Zplnomocnění: US National Institutes of Health
Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis
Y Yang, J Li, F Liu, L Huang
Molecular Therapy 20 (3), 609-615, 2012
Zplnomocnění: US National Institutes of Health
Human adipose-derived mesenchymal stem cell-secreted CXCL1 and CXCL8 facilitate breast tumor growth by promoting angiogenesis
Y Wang, J Liu, Q Jiang, J Deng, F Xu, X Chen, F Cheng, Y Zhang, Y Yao, ...
Stem Cells 35 (9), 2060-2070, 2017
Zplnomocnění: National Natural Science Foundation of China
IL-35 decelerates the inflammatory process by regulating inflammatory cytokine secretion and M1/M2 macrophage ratio in psoriasis
J Zhang, Y Lin, C Li, X Zhang, L Cheng, L Dai, Y Wang, F Wang, G Shi, ...
The Journal of Immunology 197 (6), 2131-2144, 2016
Zplnomocnění: National Natural Science Foundation of China
RETRACTED ARTICLE: SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin
L Dai, X Cui, X Zhang, L Cheng, Y Liu, Y Yang, P Fan, Q Wang, Y Lin, ...
Nature communications 7 (1), 11996, 2016
Zplnomocnění: National Natural Science Foundation of China
Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung caner
Y Yang, Y Hu, Y Wang, J Li, F Liu, L Huang
Molecular pharmaceutics 9 (8), 2280-2289, 2012
Zplnomocnění: US National Institutes of Health
Modulating the tumor microenvironment via oncolytic viruses and CSF-1R inhibition synergistically enhances anti-PD-1 immunotherapy
G Shi, Q Yang, Y Zhang, Q Jiang, Y Lin, S Yang, H Wang, L Cheng, ...
Molecular Therapy 27 (1), 244-260, 2019
Zplnomocnění: National Natural Science Foundation of China
IL‐35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells
Y Wang, Y Mao, J Zhang, G Shi, L Cheng, Y Lin, Y Li, X Zhang, Y Zhang, ...
Journal of cellular and molecular medicine 22 (2), 1014-1025, 2018
Zplnomocnění: National Natural Science Foundation of China, Department of Science …
Progress in the treatment of infantile hemangioma
ZY Chen, QN Wang, YH Zhu, LY Zhou, T Xu, ZY He, Y Yang
Annals of translational medicine 7 (22), 692, 2019
Zplnomocnění: US National Institutes of Health, National Natural Science Foundation of China
Carrier strategies boost the application of CRISPR/Cas system in gene therapy
Z Xu, Q Wang, H Zhong, Y Jiang, X Shi, B Yuan, N Yu, S Zhang, X Yuan, ...
Exploration 2 (2), 20210081, 2022
Zplnomocnění: National Natural Science Foundation of China
A mutation-independent CRISPR-Cas9–mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency
L Wang, Y Yang, C Breton, P Bell, M Li, J Zhang, Y Che, A Saveliev, Z He, ...
Science Advances 6 (7), eaax5701, 2020
Zplnomocnění: US National Institutes of Health
Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field
ZY He, K Men, Z Qin, Y Yang, T Xu, YQ Wei
Science China Life Sciences 60, 458-467, 2017
Zplnomocnění: National Natural Science Foundation of China, Department of Biotechnology, India
Applications of genome editing technology in animal disease modeling and gene therapy
Q Li, Z Qin, Q Wang, T Xu, Y Yang, Z He
Computational and structural biotechnology journal 17, 689-698, 2019
Zplnomocnění: National Natural Science Foundation of China
CRISPR/Cas9-mediated correction of human genetic disease
K Men, X Duan, Z He, Y Yang, S Yao, Y Wei
Science China Life Sciences 60, 447-457, 2017
Zplnomocnění: National Natural Science Foundation of China
A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity
H Tian, G Shi, Q Wang, Y Li, Q Yang, C Li, G Yang, M Wu, Q Xie, S Zhang, ...
Signal transduction and targeted therapy 1 (1), 1-10, 2016
Zplnomocnění: US National Institutes of Health, National Natural Science Foundation of China
Dual-AAV split prime editor corrects the mutation and phenotype in mice with inherited retinal degeneration
K She, Y Liu, Q Zhao, X Jin, Y Yang, J Su, R Li, L Song, J Xiao, S Yao, ...
Signal transduction and targeted therapy 8 (1), 57, 2023
Zplnomocnění: National Natural Science Foundation of China
CRISPR-Cas9-mediated in vivo gene integration at the albumin locus recovers hemostasis in neonatal and adult hemophilia B mice
Q Wang, X Zhong, Q Li, J Su, Y Liu, L Mo, H Deng, Y Yang
Molecular Therapy Methods & Clinical Development 18, 520-531, 2020
Zplnomocnění: National Natural Science Foundation of China
In vivo PCSK9 gene editing using an all-in-one self-cleavage AAV-CRISPR system
Q Li, J Su, Y Liu, X Jin, X Zhong, L Mo, Q Wang, H Deng, Y Yang
Molecular Therapy Methods & Clinical Development 20, 652-659, 2021
Zplnomocnění: National Natural Science Foundation of China
Informace o publikování a financování jsou automaticky vybírány počítačovým programem